UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Generated Narrative: MedicinalProductDefinition Airomir0.1Spray-SE-PLC-MPD
identifier: http://ema.europa.eu/fhir/mpId
/SE-100001594-00012324, http://ema.europa.eu/fhir/eurdId
/10330
domain: Human use
status: Current
combinedPharmaceuticalDoseForm: Pressurised inhalation, suspension
indication:
Airomir 0,1 mg/dos inhalationsspray, suspension är indicerat för symtomlindring av bronkkonstriktion vid astma och kroniskt obstruktiv lungsjukdom (KOL). Airomir är indicerat för vuxna, ungdomar och barn. För barn under 4 år ska dosering och farmakodynamik ses över.
legalStatusOfSupply: Medicinal product subject to medical prescription
classification: salbutamol
name
productName: Airomir 0,1 mg/dos inhalationsspray, suspension
part
part: Airomir
type: Invented name part
part
part: 0,1 mg/dos
type: Strength part
part
part: inhalationsspray, suspension
type: Pharmaceutical dose form part
Usages
Country Language Kingdom of Sweden Swedish